
The American Journal of Managed Care
- Online Early
- Volume 32
- Issue Early
Preventing High-Cost Failure: A Value-Based Approach to Reducing Diabetic Limb Loss in US Managed Care
Key Takeaways
- Diabetic foot deterioration commonly begins with painless, unrecognized calluses/blisters, then progresses to infection, hospitalization, and amputation, making symptom recognition a key modifiable inflection point.
- A visual, photograph-based educational library (12 languages; >200 deidentified images) delivered via QR code avoids registration, apps, IT integration, or added staffing while supporting family-assisted learning.
A scalable, symptom-focused patient education model paired with coordinated podiatric care offers managed care organizations a low-barrier strategy to reduce diabetic foot ulcers and costly amputations.
ABSTRACT
Diabetic limb loss is a high-cost, largely preventable complication in US managed care. Diabetic foot complications often follow a predictable course, from minor, often unrecognized symptoms to infection, hospitalization, and, in some cases, amputation. This commentary describes a scalable, value-based prevention strategy that integrates multilingual, culturally tailored, symptom-focused patient education with risk-stratified podiatric care. It draws on a 5-year limb preservation initiative (2019-2023) among 469 patients with diabetes receiving active cancer treatment at an academic diabetes center, in which the annual incidence of diabetic foot ulcers was 2.8% and the annual major amputation rate was 0.43%, compared with an estimated national ulcer incidence of approximately 5% and the Healthy People 2030 amputation target of 0.55%. It also draws on implementation at a federally qualified health center; a specialty diabetic foot clinic; and an endocrinology practice, where approximately 80% of eligible patients engaged with symptom-recognition education delivered by QR code, often with family involvement, without additional staffing, information technology integration, or patient registration. Because a single ulcer episode that ends in amputation can cost tens of thousands of dollars in direct medical costs alone, preventing even a small number of amputations may yield substantial savings. Diabetic limb loss reflects a system failure driven by underinvestment in prevention and delayed symptom recognition. Reframing prevention as essential health system infrastructure offers managed care organizations an opportunity to reduce avoidable costs and disparities in high-risk populations.
Am J Manag Care. 2027;33(3):In Press
doi:10.37765/ajmc.2027.90054
Takeaway Points
Diabetic limb loss is a predictable and costly complication that current reimbursement structures do little to prevent. This commentary describes a low-barrier prevention model that managed care organizations can adopt.
- Diabetic foot complications progress predictably from minor, often unrecognized symptoms to infection, hospitalization, and amputation; preventing even a small number of amputations may yield substantial cost savings for health systems.
- In a 5-year initiative (2019-2023) pairing symptom-focused patient education with risk-stratified podiatric care among 469 patients with diabetes receiving cancer treatment, the annual diabetic foot ulcer incidence was 2.8% and the annual major amputation rate was 0.43%.
- In implementation across 3 clinical settings, approximately 80% of eligible patients engaged with education delivered via QR codes, requiring no additional staffing, information technology integration, or patient registration.
- Managed care organizations can support prevention by adding foot ulcer and amputation metrics to quality frameworks, aligning incentives for early detection, and expanding access to culturally tailored education and coordinated podiatric care.
Diabetic limb loss remains one of the most costly and preventable complications of chronic disease in the United States.1-3 A common clinical presentation begins when a patient with diabetes develops a small callus or blister that, because of neuropathy, is painless and may go unrecognized.1,3 Over time, this can progress to infection, hospitalization, and, in some cases, major amputation.1,3 This pathway is predictable, yet it continues to occur across US health systems.1,3
Diabetic foot ulcers that progress to amputation are among the costliest episodes in diabetes care; in one analysis, the mean cost of an ulcer episode that ended in amputation was $44,790,4 a figure that excludes the costs of rehabilitation, prosthetics, disability, and lost productivity that often follow. Despite these costs, health systems remain disproportionately focused on late-stage intervention rather than prevention.2,4 This raises a central question: Why do these episodes continue to occur repeatedly within the current health care system?
Recent federal policy shifts, including the overhaul of Medicare payment for skin substitutes in the calendar year 2026 Physician Fee Schedule final rule, which CMS adopted in response to rapid growth in spending on these wound care products,5 underscore a critical inflection point: Prevention is no longer optional, but economically necessary for sustainable health system performance. In this commentary, we describe a scalable prevention model that combines multilingual, culturally tailored, symptom-focused patient education with risk-stratified podiatric care and consider its implications for managed care.
A Structural Gap in Prevention
The persistence of diabetic limb loss reflects a broader structural issue in US health care: underinvestment in prevention despite its high return.2,4 Current reimbursement models are structured to support procedural and late-stage care, in which intervention is necessary to prevent catastrophic outcomes such as amputation, whereas early detection and prevention—including patient education and risk-stratified podiatric care—remain comparatively underfunded.2 This imbalance creates limited incentives for early involvement of podiatric specialists and other clinicians with expertise in diabetic foot care, despite their potential to reduce downstream complications and costs.1,3,6
Health systems typically measure services delivered—procedures, visits, and admissions—but rarely track complications avoided.2,5 As a result, prevention is not only underfunded but also underrecognized. The financial benefits of prevention are often fragmented, with savings accruing across different stakeholders, reducing incentives for early intervention.2,5
Managed care organizations may benefit from establishing dedicated diabetic limb preservation programs, led by clinicians with specialized expertise in diabetic foot care—including podiatric specialists—and supported by public health education specialists to design, implement, and continuously update multilingual, culturally tailored diabetic foot patient education strategies for culturally diverse populations across the United States.1,3
Disparities in diabetic limb loss further underscore the urgency of prevention.7 Black, Native American, and Hispanic individuals have higher rates of diabetes-related amputation than non-Hispanic White individuals, as do low-income and rural populations.7 These patterns reflect gaps in early recognition, access, and preventive care—areas where scalable patient education and coordinated specialty involvement may have the greatest impact.1,3,7
A Scalable Prevention Model
One promising approach is to improve early symptom recognition through patient-centered education.1,3 Early signs of diabetic foot complications—including calluses, foot deformities, minor skin and nail changes, small blisters, intermittent pain, mild swelling, and sensory changes—are often present but not recognized as clinically significant, leading to delays in care.1,3
A multilingual, culturally tailored, symptom-focused patient education strategy, combined with risk-stratified podiatric care, may shift detection earlier in the disease trajectory.1,3,5
The patient education strategy described here illustrates how a low-barrier, visual educational approach may influence patient behavior by facilitating earlier recognition of diabetic foot abnormalities. Although effective prevention requires coordinated efforts from primary care physicians, endocrinologists, podiatrists, nurses, diabetes educators, and community health centers, its success also depends on how preventive education is delivered and integrated into routine clinical care.
Conventional patient education often relies on text-heavy descriptions or generic illustrations of medical conditions that many patients have never personally encountered. In contrast, this intervention employed a low-barrier, visual educational approach built around a library of more than 200 real-world, deidentified clinical photographs selected from more than 10,000 diabetic foot cases accumulated during 4 decades of academic and private practice. The resource, Diabetes Guardians 2001 (DG2001), was developed by one of the authors (PH), and the photographs come from his academic and private practice and have not been published elsewhere. DG2001 comprises 16 chapters, is available in 12 languages, and can be accessed by health systems at www.dg2001.com. By enabling patients to compare subtle changes in their own feet with authentic clinical images, the intervention was designed to facilitate earlier recognition of potentially significant findings and encourage timely medical evaluation before ulceration or infection develops. Delivered through simple QR codes without requiring applications, registration, or collection of personally identifiable information, the intervention minimized barriers to engagement and could be readily incorporated into routine diabetes care across primary care practices, endocrinology clinics, community health centers, and specialty podiatric services.
Importantly, this approach is scalable across diverse health systems because it requires minimal infrastructure, no additional staffing, no patient registration, no integration with existing information technology systems, and no disruption to clinical workflow (PH, unpublished observations).
In real-world implementation across a federally qualified health center, a specialty diabetic foot clinic, and an academic endocrinology practice, approximately 80% of eligible patients (188 of 242 [78%]) engaged with symptom-recognition education, with engagement defined as scanning the QR code and opening at least 1 chapter (PH, unpublished data). Patients frequently revisited content and involved family members, particularly in the setting of diabetes-related visual impairment, according to these unpublished data. These observations suggest that patient engagement need not be a barrier to prevention and that delayed recognition of early symptoms may be an important, modifiable target.1,3
Clinical and Economic Impact
In a 5-year clinical implementation (2019-2023) within the Department of Diabetes, Endocrinology and Metabolism at City of Hope among 469 patients with diabetes receiving active cancer treatment, previously published by one of the authors (PH), the annual incidence of diabetic foot ulcers was 2.8% and the annual major amputation rate was 0.43%.6 By comparison, the annual incidence of diabetic foot ulcers in the United States has been estimated at approximately 5%,5 and the Healthy People 2030 target is an annual rate of 5.5 amputations per 1000 adults with diagnosed diabetes (0.55%), a national public health benchmark established by HHS.8
The economic implications are substantial.4 Preventing even a small number of amputations can generate meaningful savings.4 For example, at the mean cost of $44,790 for an ulcer episode that ends in amputation,4 preventing 10 such episodes annually could avoid approximately $450,000 in direct medical costs within a single health system, before rehabilitation, long-term care, and productivity losses are considered.
Importantly, the benefits of prevention must be evaluated over an appropriate time horizon.2,6 Diabetic foot complications develop over years, and the full impact of prevention strategies, including repeated patient education, may not be immediately observable.2-4 The outcomes described above reflect 5 years of sustained implementation, consistent with the long natural history of diabetic foot disease, which positions prevention as a long-term investment rather than a source of short-term savings.4,6
Implications for Managed Care
For managed care organizations, diabetic limb loss represents a high-cost, high-impact target for intervention.4,6 Prevention-focused strategies align directly with value-based care objectives by reducing avoidable complications and improving population health outcomes.2-4
Scaling prevention will require the following:
integration of diabetic foot ulcer and amputation metrics into quality frameworks such as the Healthcare Effectiveness Data and Information Set2;
alignment of incentives to support early detection and prevention2;
deployment of multilingual, culturally tailored patient education in underserved populations1,4,5;
expansion of access to coordinated podiatric care within primary care and community settings1,3; and
adoption of low-barrier, visual patient education using authentic clinical photographs rather than relying solely on conventional text-based educational materials to facilitate earlier symptom recognition and timely care seeking.
Reframing prevention as essential health system infrastructure, rather than discretionary spending, is critical.2,5
Conclusion
Diabetic limb loss is not simply a clinical complication. It is a predictable and costly system failure.2,5 Despite clear opportunities for prevention, current health care structures continue to prioritize late-stage intervention over early detection.2,5 Prevention offers a high-return opportunity to reduce both cost and human burden but requires sustained investment and alignment of incentives across stakeholders.2-4
Reframing prevention as essential health system infrastructure—supported by scalable patient education and coordinated podiatric care—may be one of the most effective strategies for reducing avoidable complications and costs in high-risk populations.1,3,8 Without such changes, health systems will continue to incur preventable harm and unnecessary expenditures despite the availability of practical, implementable solutions.2,5,8
Acknowledgment
Artificial intelligence–assisted tools were used for spelling and grammar. All content, analysis, and conclusions are the responsibility of the authors.
Author Affiliations: City of Hope (PH), Duarte, CA; Harvard Medical School (JG), Boston, MA.
Source of Funding: None.
Author Disclosures: PH is the author of What’s the Foot Got to Do With My Diabetes? and founder of Diabetes Guardians, LLC, which publishes the book and the DG2001 patient education program described in this article. Diabetes Guardians, LLC is owned by members of PH’s family. PH receives no salary, royalties, or other compensation from Diabetes Guardians, LLC. JG reports no relationship or financial interest with any entity that would pose a conflict of interest with the subject matter of this article.
Authorship Information: Concept and design (PH); acquisition of data (PH); analysis and interpretation of data (PH); drafting of the manuscript (PH, JG); critical revision of the manuscript for important intellectual content (PH, JG); statistical analysis (PH); and administrative, technical, or logistic support (JG).
Address Correspondence to: Paul Han, DPM, MS, City of Hope, 21500 S Pioneer Blvd, Suite 107, Hawaiian Gardens, CA 90716. Email: paulyhan1191@gmail.com.
REFERENCES
1. American Diabetes Association Professional Practice Committee. 12. Retinopathy, neuropathy, and foot care: standards of care in diabetes 2025. Diabetes Care. 2025;48(suppl 1):S252-S265. doi:10.2337/dc25-S012
2. Frykberg RG, Vileikyte L, Boulton AJM, Armstrong DG. The at-risk diabetic foot: time to focus on prevention. Diabetes Care. 2022;45(10):e144-e145. doi:10.2337/dc22-1111
3. Schaper NC, van Netten JJ, Apelqvist J, et al; IWGDF Editorial Board. Practical guidelines on the prevention and management of diabetes-related foot disease (IWGDF 2023 update). Diabetes Metab Res Rev. 2024;40(3):e3657. doi:10.1002/dmrr.3657
4. Driver VR, Fabbi M, Lavery LA, Gibbons G. The costs of diabetic foot: the economic case for the limb salvage team. J Am Podiatr Med Assoc. 2010;100(5):335-341. doi:10.7547/1000335
5. Medicare and Medicaid programs; CY 2026 payment policies under the physician fee schedule and other changes to Part B payment and coverage policies; Medicare Shared Savings Program requirements; and Medicare Prescription Drug Inflation Rebate Program. Fed Regist. 2025;90(212):49266-50481.
6. Han P. A novel diabetic limb preservation initiative using symptom-focused education and coordinated podiatric care. J Am Podiatr Med Assoc. 2026;116(2):25108. doi:10.7547/25-108
7. Clayton EO, Njoku-Austin C, Scott DM, Cain JD, Hogan MV. Racial and ethnic disparities in the management of diabetic feet. Curr Rev Musculoskelet Med. 2023;16(11):550-556. doi:10.1007/s12178-023-09867-7
8. Healthy People 2030: reduce the rate of foot and leg amputations in adults with diabetes — D-08. HHS Office of Disease Prevention and Health Promotion. Accessed April 8, 2026. https://odphp.health.gov/healthypeople/objectives-and-data/browse-objectives/diabetes/reduce-rate-foot-and-leg-amputations-
adults-diabetes-d-08/data
Related to this article



